$150,000 of CLENE NANOMEDICINE INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"ALS"
You can find more data on corporate lobbying on Quiver Quantitative.
CLNN Insider Trading Activity
CLNN insiders have traded $CLNN stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CLNN stock by insiders over the last 6 months:
- MARK MORTENSON (Chief Science Officer) purchased 20,512 shares.
- ROBERT DEE ETHERINGTON (Chief Executive Officer) purchased 10,000 shares.
- DAVID J MATLIN purchased 92,307 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
